Related Experiment Video
Updated: Oct 8, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Predictive value of using plasma long non-coding RNAs ANRIL and HOXA11-AS for in-stent restenosis
Zhijiang Jin1,2, Hongfeng Shen1,2, Wei Cha1,2
1Department of Cardiology, The Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang 312000, P.R. China.
Insights
Plasma levels of long non-coding RNA (lncRNA) ANRIL and HOXA11-AS can help predict in-stent restenosis (ISR) after coronary stent implantation. Elevated ANRIL and reduced HOXA11-AS levels are associated with increased ISR risk.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- In-stent restenosis (ISR) is a significant complication following coronary stent implantation.
- Predicting ISR risk is crucial for effective prevention strategies.
- Current predictors for ISR remain limited.
Purpose of the Study:
- To investigate the association between plasma long non-coding RNA (lncRNA) levels and ISR.
- To identify potential lncRNA biomarkers for ISR risk stratification.
Main Methods:
- Quantitative reverse transcription-polymerase chain reaction (RT-qPCR) was used to measure plasma lncRNA expression in 410 patients.
- Patients received drug-eluting stents (DES) and were followed for 12-36 months.
- Coronary angiography assessed ISR, defined as >50% diameter stenosis.
Main Results:
- RNA antisense non-coding RNA at the INK4 locus (ANRIL) was upregulated in ISR patients.
- HOXA11 antisense (HOXA11-AS) was downregulated in ISR patients.
- Logistic regression identified ANRIL as a risk factor and HOXA11-AS as a protective factor for ISR. ROC analysis showed combined ANRIL and HOXA11-AS levels improved ISR prediction accuracy (auROC=0.844).
Conclusions:
- Increased plasma ANRIL and decreased HOXA11-AS expression are associated with ISR.
- Combined detection of ANRIL and HOXA11-AS plasma levels offers superior predictive value for ISR.
- Multiplex detection of lncRNAs holds promise for future ISR prediction strategies.
Abstract:
In-stent restenosis (ISR) can pose serious challenges for cardiologists following coronary stent implantation. Early identification of patients at high risk of ISR is considered to be effective for its prevention. However, factors that can reliably predict the risk of ISR remain elusive at present. The present study aimed to investigate the possible association between plasma long non-coding RNA (lncRNA) levels and ISR. A total of 410 patients with single-vessel lesion who received drug-eluting stents (DES) were included in the present study. After 12-36 months of follow-up, coronary angiography was performed and ISR was defined as >50% diameter stenosis at follow-up. RT-qPCR was used to measure lncRNA expression. Expression of the lncRNA RNA antisense non-coding RNA at the INK4 locus (ANRIL) was found to be upregulated whereas the lncRNA homeobox A11 antisense (HOXA11-AS) was downregulated in the plasma of patients with ISR compared with that from patients without ISR (P<0.001). Logistic regression analysis revealed that ANRIL [odds ratio (OR)=2.95; 95% confidence interval (CI)=1.68-8.08] was an independent risk factor for ISR, whilst HOXA11-AS (OR=0.58; 95% CI=0.48-0.71) was found to be an independent protective factor for ISR. Receiver operating characteristic (ROC) analysis demonstrated that high ANRIL expression [area under the ROC (auROC)=0.755; 95% CI=0.702-0.803] and low HOXA11-AS levels (auROC=0.712; 95% CI=0.657-0.763) predicted a high risk for ISR, and the combined score of ANRIL and HOXA11-AS (auROC=0.844; 95% CI=0.798-0.884) was more efficient at predicting ISR than either ANRIL or HOXA11-AS alone (P<0.001). In conclusion, increased ANRIL and decreased HOXA11-AS expressions were associated with ISR. However, combined ANRIL and HOXA11-AS plasma levels proved to be more effective at predicting ISR compared with either ANRIL or HOXA11-AS alone, suggesting that the multiplex detection of lncRNAs could be used to predict ISR in the future.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019